16-23380584-C-T

Variant summary

Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_000336.3(SCNN1B):​c.1706C>T​(p.Ala569Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000571 in 1,614,148 control chromosomes in the GnomAD database, including 8 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00060 ( 2 hom., cov: 33)
Exomes 𝑓: 0.00057 ( 6 hom. )

Consequence

SCNN1B
NM_000336.3 missense

Scores

5
14

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:5

Conservation

PhyloP100: 3.15
Variant links:
Genes affected
SCNN1B (HGNC:10600): (sodium channel epithelial 1 subunit beta) Nonvoltage-gated, amiloride-sensitive, sodium channels control fluid and electrolyte transport across epithelia in many organs. These channels are heteromeric complexes consisting of 3 subunits: alpha, beta, and gamma. This gene encodes the beta subunit, and mutations in this gene have been associated with pseudohypoaldosteronism type 1 (PHA1), and Liddle syndrome. [provided by RefSeq, Apr 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0057277083).
BP6
Variant 16-23380584-C-T is Benign according to our data. Variant chr16-23380584-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 229239.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Uncertain_significance=2, Benign=3}.
BS1
Variant frequency is greater than expected in population mid. gnomad4_exome allele frequency = 0.000568 (830/1461816) while in subpopulation MID AF= 0.0139 (80/5766). AF 95% confidence interval is 0.0114. There are 6 homozygotes in gnomad4_exome. There are 439 alleles in male gnomad4_exome subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 2 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
SCNN1BNM_000336.3 linkuse as main transcriptc.1706C>T p.Ala569Val missense_variant 13/13 ENST00000343070.7 NP_000327.2 P51168-1B2R812

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
SCNN1BENST00000343070.7 linkuse as main transcriptc.1706C>T p.Ala569Val missense_variant 13/131 NM_000336.3 ENSP00000345751.2 P51168-1

Frequencies

GnomAD3 genomes
AF:
0.000611
AC:
93
AN:
152214
Hom.:
2
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000965
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000851
Gnomad ASJ
AF:
0.00490
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00145
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0190
Gnomad NFE
AF:
0.000632
Gnomad OTH
AF:
0.00143
GnomAD3 exomes
AF:
0.000701
AC:
176
AN:
251128
Hom.:
2
AF XY:
0.000810
AC XY:
110
AN XY:
135810
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000723
Gnomad ASJ exome
AF:
0.00546
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000490
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000573
Gnomad OTH exome
AF:
0.00261
GnomAD4 exome
AF:
0.000568
AC:
830
AN:
1461816
Hom.:
6
Cov.:
32
AF XY:
0.000604
AC XY:
439
AN XY:
727218
show subpopulations
Gnomad4 AFR exome
AF:
0.000627
Gnomad4 AMR exome
AF:
0.000894
Gnomad4 ASJ exome
AF:
0.00612
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.000661
Gnomad4 FIN exome
AF:
0.0000187
Gnomad4 NFE exome
AF:
0.000357
Gnomad4 OTH exome
AF:
0.00121
GnomAD4 genome
AF:
0.000597
AC:
91
AN:
152332
Hom.:
2
Cov.:
33
AF XY:
0.000631
AC XY:
47
AN XY:
74482
show subpopulations
Gnomad4 AFR
AF:
0.0000962
Gnomad4 AMR
AF:
0.000849
Gnomad4 ASJ
AF:
0.00490
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00124
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000632
Gnomad4 OTH
AF:
0.00142
Alfa
AF:
0.000816
Hom.:
0
Bravo
AF:
0.000620
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000930
AC:
8
ExAC
AF:
0.000708
AC:
86
Asia WGS
AF:
0.00144
AC:
5
AN:
3478
EpiCase
AF:
0.00104
EpiControl
AF:
0.00148

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:5
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Liddle syndrome 1 Benign:2
Likely benign, criteria provided, single submitterclinical testingJohns Hopkins Genomics, Johns Hopkins UniversityDec 20, 2019- -
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineMar 20, 2017The p.Ala569Val variant in SCNN1B has been identified by our laboratory in one i ndividual with bronchiectasis. This variant has been identified in 0.1% (69/6637 8) of European chromosomes by the Exome Aggregation Consortium (ExAC, http://exa c.broadinstitute.org; dbSNP rs140927806). This variant has also been reported in ClinVar (Variant ID:229239). Computational prediction tools and conservation a nalysis do not provide strong support for or against an impact to the protein. I n summary, the clinical significance of the p.Ala569Val variant is uncertain. -
Pseudohypoaldosteronism, type IB1, autosomal recessive Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -
SCNN1B-related disorder Benign:1
Likely benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesDec 08, 2022This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
not provided Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpDec 22, 2023- -
Bronchiectasis with or without elevated sweat chloride 1 Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.088
BayesDel_addAF
Benign
-0.22
T
BayesDel_noAF
Benign
-0.18
CADD
Benign
18
DANN
Uncertain
1.0
DEOGEN2
Benign
0.30
T;.;.;.
Eigen
Benign
-0.40
Eigen_PC
Benign
-0.32
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Benign
0.81
T;T;T;T
M_CAP
Uncertain
0.087
D
MetaRNN
Benign
0.0057
T;T;T;T
MetaSVM
Benign
-0.63
T
MutationAssessor
Uncertain
2.7
M;.;.;.
PrimateAI
Benign
0.46
T
PROVEAN
Benign
-1.4
N;N;N;N
REVEL
Benign
0.25
Sift
Benign
0.12
T;T;T;T
Sift4G
Uncertain
0.037
D;D;D;D
Polyphen
0.34
B;.;.;.
Vest4
0.25
MVP
0.85
MPC
0.32
ClinPred
0.045
T
GERP RS
4.8
Varity_R
0.087
gMVP
0.63

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs140927806; hg19: chr16-23391905; API